Table 2.
Effect of DKK-proteins in acute and chronic renal tubular injury
Effect of DKK-proteins in acute and chronic renal tubular injury | ||||
---|---|---|---|---|
Species | Protein | Injury model | Effect | Reference |
mouse | DKK1 recombinant | UUO 7–14 days | Reduction of cMyc, twist, collagen, fibronectin, fibrosis | He W et al., JASN 20:765–766, 2009 [10] |
mouse | Recombinant C2 cysteine-rich domain of DKK2 infused | Bilateral IRI (infusion starts at day 0 or 1) | Tubular regeneration and faster fall of serum creatinine | Lin SL, PNAS 107:4194–4199, 2010 [18] |
human | SNPs of DKK3 and mRNA DKK3 | Adult polycystic kidney disease (ADPKD) | Association with large cysts | Liu M et al., JASN 21:1510–1520, 2010 [19] |
mouse | DKK1 AAV-increased circulating DKK1 | UUO 4 days/unilateral IRI | DKK1 binding to LRP6 blocking PDGFBB pathway inhibiting inflammation, fibrosis | Ren S et al., PNAS 110:1440–1445, 2013 [30] |
mouse/human | DKK3 deficiency | UUO 21 days/adenine nephropathy28 days/human urine | General and tubular specific DKK3 deficiency with reduction of tubular epithelial dedifferentiation and decrease of fibrosis. In man, DKK3 in urine: marker of extent of tubular atrophy and fibrosis | Federico G et al., JCI Insight 1:e84916, 2016 [6] |
mouse | DKK1 recombinant | UUO | Inflammation, fibrosis downregulated | Johnson BG et al., JASN 6080826, 2017 [13] |
IRI ischemia reperfusion injury, UUO unilateral ureteral obstruction